Francesco Nicoldi
In the coming decades, there will likely be an increase in pancreatic cancer mortality. A poor prognosis for this aggressive cancer is caused by late detection and therapy resistance. Harnessing the microbiome may present potential opportunities for diagnostic and therapeutic approaches, according to mounting evidence that host-microbiome interactions play a critical role in the development of pancreatic cancer
